A Dual Electrospray/Photoionization Source

Information

  • Research Project
  • 6444232
  • ApplicationId
    6444232
  • Core Project Number
    R43GM063430
  • Full Project Number
    1R43GM063430-01A1
  • Serial Number
    63430
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/2002 - 22 years ago
  • Project End Date
    9/30/2002 - 22 years ago
  • Program Officer Name
    SWAIN, AMY L
  • Budget Start Date
    4/1/2002 - 22 years ago
  • Budget End Date
    9/30/2002 - 22 years ago
  • Fiscal Year
    2002
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    3/29/2002 - 22 years ago
Organizations

A Dual Electrospray/Photoionization Source

We propose a method to integrate an electrospray (ES) device to an atmospheric pressure photoionization (P I) source. We will employ a proprietary method to generate charged droplets that will undergo charge-repulsion to form volatilized analyte without producing ES positive ions. The positive ion spectrum will be due to PI only. By this means, the benefits of PI can be extended to non-volatile and thermally- labile compounds. PI has proven to be a general purpose ionization source for analyzing a wide variety of compounds, in many cases compounds not detectable by ES ionization (ESI) or atmospheric pressure chemical ionization (A PCI). PI is particularly well suited for drug-like compounds, and is much less susceptible to competition-for- charge and ion-suppression that affects ESI and APCI mass spectra. This proposal is a resubmission that contains new results that greatly raise the probability of success. We are confident that if provided SBIR seed money to test the feasibility in Phase I and solve the R&D issues in Phase II, that the ES/PI source would be immediately commercializable. The ES/PI source could also operate as an ES ionization source thereby providing dual ESI and PI capabilities for large molecules. The latter strategy would lead to rapid acceptance and widespread use in the pharmaceutical industry. PROPOSED COMMERCIAL APPLICATION: The pharmaceutical industry places increasingly greater demands on molecular analysis technology in terms of speed, quantitation, and generality. Development of a dual ESI/PI source would greatly expand capabilities and would be widely accepted into use as an enhanced ESI source.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    99291
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:99291\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SYAGEN TECHNOLOGY, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    TUSTIN
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92780
  • Organization District
    UNITED STATES